Because polypeptide comprises a Tenth of Fibronectin Type III domain and binds to Interleukin 23 (il-23)； Pharmaceutical composition comprising the polypeptide； procedure for regularThe Pathogenicity of Th17 lymphocytes which comprises contacting the above-mentioned POLYPEPTIDE WITH IL - 23.

• 收藏
• 分享

专利权人:

BRISTOL-MYERS SQUIBB COMPANY

发明人:

BUSH ALEX,DASGUPTA RUCHIRA,ENGLE LINDA,SCHNEEWEIS LUMELLE

申请号：

CL2012002296

公开号：

CL2012002296A1

申请日:

2012.08.17

申请国别(地区):

CL

年份:

2013

代理人:

摘要：

Because polypeptide comprises a Tenth of Fibronectin Type III domain and binds to Interleukin 23 (il-23)； Pharmaceutical composition comprising Said polypeptide； procedure for regularThe Pathogenicity of Th17 lymphocytes which comprises contacting the above-mentioned POLYPEPTIDE WITH IL - 23.<；p>；Polipé；ptido porque comprende un dominio decimo de fibronectina de tipo III y que se une a interleucina 23 (IL-23)； composició；n farmacé；utica que comprende dicho polipé；ptido； procedimiento para regular la patogenicidad de los linfocitos th17 que comprende poner en contacto el polipé；ptido antes mencionado con IL-23.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/